European randomized, multicenter study of goserelin (Zoladex) in the management of mastalgia

American Journal of Obstetrics and Gynecology

Volumn 191, Issue 6, 2004, Pages 1942-1949

  Mansel, Robert E ^a   Goyal, Amit ^a   Preece, Paul ^b   Leinster, Sam ^c   Maddox, Paul R ^d   Gateley, Christopher ^e   Kubista, Ernst ^f   Von Fournier, Dietrich ^g  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b NINEWELLS HOSPITAL   (United Kingdom)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d ROYAL UNITED HOSPITAL   (United Kingdom)

^e ROYAL GWENT HOSPITAL   (United Kingdom)

^f UNIVERSITY OF VIENNA   (Austria)

^g UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Breast pain; Cardiff breast pain chart; Goserelin; Mastalgia; Zoladex

Indexed keywords

GOSERELIN; PLACEBO;

ACNE; ADULT; ANKLE EDEMA; ARTICLE; BREAST ATROPHY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERABILITY; FEMALE; HAIR DISEASE; HEADACHE; HIRSUTISM; HOT FLUSH; HUMAN; IRRITABILITY; LIBIDO DISORDER; MAJOR CLINICAL STUDY; MASTALGIA; MENSTRUAL CYCLE; MENTAL STRESS; MULTICENTER STUDY; PAIN ASSESSMENT; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; SIDE EFFECT; SKIN DISEASE; VAGINAL DRYNESS;

ADULT; ANALYSIS OF VARIANCE; BREAST DISEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GOSERELIN; HUMANS; INJECTIONS, SUBCUTANEOUS; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PATIENT SATISFACTION; PROBABILITY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 10044247017     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2004.06.100     Document Type: Article

References (20)

1. R.E. Mansel ABC of breast diseases. Breast pain BMJ 309 1994 866 868
2. P.R. Maddox, and R.E. Mansel Management of breast pain and nodularity World J Surg 13 1989 699 705
3. L.E. Hughes, and R.E. Mansel Breast Pain and Nodularity L.E. Hughes R.E. Mansel D.J.T. Webster Benign disorders and diseases of the breast 2000 W.B. Saunders London 95 122
4. Cyclical breast pain - what works and what doesn't Drug Ther Bull 30 1992 1 3
5. D.P. Rose, A.P. Boyar, C. Cohen, and L.E. Strong Effect of a low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroids and gonadotropins J Natl Cancer Inst 78 1987 623 626
6. D.Y. Wang, and I.S. Fentiman Epidemiology and endocrinology of benign breast disease Breast Cancer Res Treat 6 1985 5 36
7. J.R. Wisbey, S. Kumar, R.E. Mansel, P.E. Peece, J.K. Pye, and L.E. Hughes Natural history of breast pain Lancet 2 1983 672 674
8. H.M. Fraser, and J. Sandow Suppression of follicular maturation by infusion of a luteinizing hormone-releasing hormone agonist starting during the late luteal phase in the stumptailed macaque monkey J Clin Endocrinol Metab 60 1985 579 584
9. R.W. Shaw An open randomized comparative study of the effect of goserelin depot and danazol in the treatment of endometriosis. Zoladex Endometriosis Study Team Fertil Steril 58 1992 265 272
10. E.J. Thomas, J. Jenkins, E.A. Lenton, and I.D. Cooke Endocrine effects of goserelin, a new depot luteinising hormone releasing hormone agonist Br Med J (Clin Res Ed) 293 1986 1407 1408
11. M. Kaufmann, W. Jonat, U. Kleeberg, W. Eiermann, F. Janicke, and J. Hilfrich Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group J Clin Oncol 7 1989 1113 1119
12. R.W. Blamey, W. Jonat, M. Kaufmann, A.R. Bianco, and M. Namer Goserelin depot in the treatment of premenopausal advanced breast cancer Eur J Cancer 28A 1992 810 814
13. E. Bajetta, L. Celio, N. Zilembo, A. Bono, D. Galluzzo, and M.G. Zampino Ovarian function suppression with the gonadotrophin-releasing hormone (GnRH) analogue goserelin in premenopausal advanced breast cancer Tumori 80 1994 28 32
14. F. Boccardo, A. Rubagotti, A. Perrotta, D. Amoroso, M. Balestrero, and A. De Matteis Ovarian ablation versus goserelin with or without tamoxifen in pre-perimenopausal patients with advanced breast cancer: results of a multicentric Italian study Ann Oncol 5 1994 337 342
15. C.W. Taylor, S. Green, W.S. Dalton, S. Martino, D. Rector, and J.N. Ingle Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study J Clin Oncol 16 1998 994 999
16. Goyal A, Mansel RE, on behalf of the Efamast Study Group. A randomized multicenter study of gamolenic acid ('Efamast') with or without antioxidant vitamins and minerals in the management of mastalgia. Breast J, in press.
17. B.J. Harrison, P.R. Maddox, and R.E. Mansel Maintenance therapy of cyclical mastalgia using low-dose danazol J R Coll Surg Edinb 34 1989 79 81
18. P. Armitage, and G. Berry Sequential methods Statistical methods in medical research 2004 Blackwell Scientific Oxford 493 506
19. H. Hamed, M. Caleffi, M.A. Chaudary, and I.S. Fentiman LHRH analogue for treatment of recurrent and refractory mastalgia Ann R Coll Surg Engl 72 1990 221 224
20. W. Jonat, M. Kaufmann, W. Sauerbrei, R. Blamey, J. Cuzick, and M. Namer Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study J Clin Oncol 20 2002 4628 4635